Suzhou Basecare Medical (HKSE:02170) EV-to-EBIT : 0.85 (As of Jun. 21, 2024)

View and export this data going back to 2021. Start your Free Trial

What is Suzhou Basecare Medical EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Suzhou Basecare Medical's Enterprise Value is HK$-181.1 Mil. Suzhou Basecare Medical's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was HK$-211.9 Mil. Therefore, Suzhou Basecare Medical's EV-to-EBIT for today is 0.85.

The historical rank and industry rank for Suzhou Basecare Medical's EV-to-EBIT or its related term are showing as below:

HKSE:02170' s EV-to-EBIT Range Over the Past 10 Years
Min: -8.3 Med: 0.9 Max: 7.19
Current: 0.85

During the past 6 years, the highest EV-to-EBIT of Suzhou Basecare Medical was 7.19. The lowest was -8.30. And the median was 0.90.

HKSE:02170's EV-to-EBIT is ranked better than
93.96% of 447 companies
in the Medical Devices & Instruments industry
Industry Median: 19.23 vs HKSE:02170: 0.85

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Suzhou Basecare Medical's Enterprise Value for the quarter that ended in Dec. 2023 was HK$-81.7 Mil. Suzhou Basecare Medical's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was HK$-211.9 Mil. Suzhou Basecare Medical's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was 259.34%.

Suzhou Basecare Medical EV-to-EBIT Historical Data

The historical data trend for Suzhou Basecare Medical's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Suzhou Basecare Medical EV-to-EBIT Chart

Suzhou Basecare Medical Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EV-to-EBIT

Get a 7-Day Free Trial

-0.17

2.73

0.39

Suzhou Basecare Medical Semi-Annual Data
	Dec18	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
EV-to-EBIT	Get a 7-Day Free Trial					-0.17	-	2.73	-	0.39

Competitive Comparison of Suzhou Basecare Medical's EV-to-EBIT

For the Medical Devices subindustry, Suzhou Basecare Medical's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Suzhou Basecare Medical's EV-to-EBIT Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Suzhou Basecare Medical's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Suzhou Basecare Medical's EV-to-EBIT falls into.

Suzhou Basecare Medical EV-to-EBIT Calculation

Suzhou Basecare Medical's EV-to-EBIT for today is calculated as:

EV-to-EBIT	=	Enterprise Value (Today)	/	EBIT (TTM)
	=	-181.052	/	-211.875
	=	0.85

Suzhou Basecare Medical's current Enterprise Value is HK$-181.1 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Suzhou Basecare Medical's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was HK$-211.9 Mil.

Suzhou Basecare Medical (HKSE:02170) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Suzhou Basecare Medical's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Dec. 2023 )	=	EBIT	/	Enterprise Value (Q: Dec. 2023 )
	=	-211.875	/	-81.6989
	=	259.34 %

Suzhou Basecare Medical's Enterprise Value for the quarter that ended in Dec. 2023 was HK$-81.7 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Suzhou Basecare Medical's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was HK$-211.9 Mil.

Suzhou Basecare Medical EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Suzhou Basecare Medical's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Suzhou Basecare Medical (HKSE:02170) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Suzhou Basecare Medical Corp Ltd (HKSE:02170) » Definitions » EV-to-EBIT

Comparable Companies

Traded in Other Exchanges

N/A

Address

BioBay, No. 218 Xinghu Street, Unit 101, Building A3, Suzhou Industrial Park, Jiangsu Province, Suzhou, CHN, 215000

Website

https://www.basecare.cn

Suzhou Basecare Medical Corp Ltd is engaged in providing genetic testing solutions for assisted human reproduction. The company generates revenues from Sales of testing kits, followed by Sales of testing devices and instruments. Basecare focuses on the assisted reproductive sector, such as pre-implantation genetic screening and diagnosis, non-invasive prenatal DNA testing, and chromosome abnormalities testing. It generates revenue from China.

Executives

Orbimed Capital Llc	2102 Investment manager
Lake Bleu Prime Healthcare Master Fund Limited	2201 Interest of corporation controlled by you
Orbimed Partners Master Fund Limited	2101 Beneficial owner
Dawn Capital Fund	2101 Beneficial owner
Dawn Capital Limited	2102 Investment manager
Hh Spr-xiv Cy Holdings Limited	2201 Interest of corporation controlled by you
Hh Spr-xiv Hk Holdings Limited	2101 Beneficial owner
Hh Spr-xiv Holdings L.p.	2201 Interest of corporation controlled by you
Hillhouse Fund Iv, L.p.	2201 Interest of corporation controlled by you
Hillhouse Investment Management, Ltd.	2102 Investment manager

Suzhou Basecare Medical (HKSE:02170) Headlines

No Headlines